Kymera Therapeutics (KYMR) EV/EBIT: History & Chart

Kymera Therapeutics, Inc.(KYMR)

Biotechnology · Watertown, MA

$104.34-5.51 (-5.02%)

Delayed quote: Oct 6, 2026, 12:30 PM EDT

About Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.

Watertown, MA

273 employees

www.kymeratx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Nello Mainolfi

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Kymera Therapeutics, Inc. (KYMR)	$8.58B	N/A	N/A	N/A	N/A
Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›	$8.77B	N/A	57.60x	57.60x	57.60x
Oscar Health, Inc. (OSCR)vs ›	$8.42B	7.65x	269.89x	133.90x	133.90x
Protagonist Therapeutics, Inc. (PTGX)vs ›	$8.88B	145.19x	233.04x	100.55x	100.55x
Axsome Therapeutics, Inc. (AXSM)vs ›	$8.99B	N/A	N/A	N/A	N/A
Bruker Corporation (BRKRP)vs ›	$9.00B	84.86x	350.77x	341.43x	341.43x
Caris Life Sciences, Inc. (CAI)vs ›	$7.93B	50.16x	45.18x	45.18x	45.18x
Bruker Corporation (BRKR)vs ›	$9.29B	87.11x	55.05x	39.77x	33.84x
Insulet Corp. (PODD)vs ›	$9.39B	19.01x	34.29x	59.67x	167.52x
Praxis Precision Medicines, Inc. (PRAX)vs ›	$7.73B	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Kymera Therapeutics, Inc. (KYMR)

$8.58B

N/A

Arrowhead Pharmaceuticals, Inc. (ARWR)vs ›

$8.77B

N/A

57.60x

Oscar Health, Inc. (OSCR)vs ›